Postmarketing Observational Study of Tolterodine Treatment on Overactive Bladder in Real Life Setting.

Trial Profile

Postmarketing Observational Study of Tolterodine Treatment on Overactive Bladder in Real Life Setting.

Completed
Phase of Trial: Phase IV

Latest Information Update: 13 Jun 2012

At a glance

  • Drugs Tolterodine (Primary)
  • Indications Overactive bladder
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms POTTOR
  • Sponsors Pfizer
  • Most Recent Events

    • 10 Dec 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top